DK0464124T3 - Peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af et pattedyr mod LHRH og fremgangsmåde til forbedring af kødkvaliteten hos grise - Google Patents

Peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af et pattedyr mod LHRH og fremgangsmåde til forbedring af kødkvaliteten hos grise

Info

Publication number
DK0464124T3
DK0464124T3 DK90905697.0T DK90905697T DK0464124T3 DK 0464124 T3 DK0464124 T3 DK 0464124T3 DK 90905697 T DK90905697 T DK 90905697T DK 0464124 T3 DK0464124 T3 DK 0464124T3
Authority
DK
Denmark
Prior art keywords
pigs
peptide
immunizing
vaccine
improving
Prior art date
Application number
DK90905697.0T
Other languages
Danish (da)
English (en)
Inventor
Robert Hans Meloen
Cornelis Johannes G Wensing
Original Assignee
Stichting Centr Diergeneeskund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Centr Diergeneeskund filed Critical Stichting Centr Diergeneeskund
Application granted granted Critical
Publication of DK0464124T3 publication Critical patent/DK0464124T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
DK90905697.0T 1989-03-23 1990-03-22 Peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af et pattedyr mod LHRH og fremgangsmåde til forbedring af kødkvaliteten hos grise DK0464124T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8900726A NL8900726A (nl) 1989-03-23 1989-03-23 Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.

Publications (1)

Publication Number Publication Date
DK0464124T3 true DK0464124T3 (da) 1994-05-02

Family

ID=19854349

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90905697.0T DK0464124T3 (da) 1989-03-23 1990-03-22 Peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af et pattedyr mod LHRH og fremgangsmåde til forbedring af kødkvaliteten hos grise

Country Status (11)

Country Link
EP (1) EP0464124B1 (de)
JP (1) JP3098771B2 (de)
AT (1) ATE103297T1 (de)
CA (1) CA2049325C (de)
DE (1) DE69007616T2 (de)
DK (1) DK0464124T3 (de)
ES (1) ES2050435T3 (de)
HU (1) HU214742B (de)
NL (1) NL8900726A (de)
RU (1) RU2078770C1 (de)
WO (1) WO1990011298A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
DK0501882T3 (da) * 1991-03-01 2000-12-11 Merial Sas Fremgangsmåde til anti-LHRH immunoneutralisering af ikke-kastrerede husdyrhanner og peptider dertil
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
ZA934199B (en) * 1992-06-18 1994-01-10 Akzo Nv Carrier system against gnrh
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
EP0698040A4 (de) * 1993-05-20 1999-01-07 Biotech Australia Pty Ltd Lhrh antagonisten
US6761890B1 (en) 1995-06-07 2004-07-13 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
USRE39048E1 (en) 1995-06-07 2006-03-28 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
DK0832107T3 (da) * 1995-06-07 2001-11-19 Dlo Inst Voor Dierhouderij En Forbedret peptid, immunogen sammensætning og vaccine eller medicinsk præparat, fremgangsmåde til immunisering af dyr mod hormonet LHRH samt analoge af LHRH-tandempeptid-gentagelsespeptidet og deres andvendelse som vaccine
BR9709993A (pt) * 1996-06-25 1999-08-10 Stichting Inst Dierhouderij Vacina preparação de vacina composição processo para produção de uma preparação imugênica e preparação imugênica
AUPO776897A0 (en) 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
NZ509137A (en) * 1998-06-04 2004-01-30 Metamorphix Internat Inc Methods for reducing GnRH levels in prepubertal vertebrates as an alternative to surgical sterilisation
US6838553B1 (en) * 1999-10-05 2005-01-04 Academia Sinica Peptide repeat immunogens
PT1317478E (pt) * 2000-09-12 2007-03-30 Pepscan Systems Bv Distinção entre a gnrh-i e a gnrh-ii
CA2523197C (en) 2003-04-22 2016-05-24 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Peptide vectors
CU23739A1 (es) 2008-09-30 2011-12-28 Ct Ingenieria Genetica Biotech Composición farmacéutica utilizando combinaciones de variantes de la hormona liberadora de las gonadotropinas (gnrh) como inmunógeno
RU2521652C2 (ru) * 2010-12-27 2014-07-10 Общество с ограниченной ответственностью "Научно-внедренческое предприятие "Астрафарм" РЕКОМБИНАНТНАЯ ДНК, КОДИРУЮЩАЯ ГИБРИДНЫЙ ВАКЦИННЫЙ БЕЛОК GHbc ДЛЯ РЕГУЛЯЦИИ ПОЛОВОЙ ФУНКЦИИ У ЖИВОТНЫХ, СОСТОЯЩИЙ ИЗ НУКЛЕОКАПСИДНОГО БЕЛКА ВИРУСА ГЕПАТИТА В ЧЕЛОВЕКА СЛИТОГО С ГОНАДОЛИБЕРИНОМ
AU2014401765A1 (en) * 2014-07-25 2017-01-12 United Biomedical, Inc. Immunogenic LHRH composition and use thereof in pigs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
WO1988005308A1 (en) * 1987-01-14 1988-07-28 Commonwealth Scientific And Industrial Research Or Anti reproductive hormone

Also Published As

Publication number Publication date
JP3098771B2 (ja) 2000-10-16
DE69007616T2 (de) 1994-06-30
HU214742B (hu) 1998-10-28
EP0464124B1 (de) 1994-03-23
ATE103297T1 (de) 1994-04-15
JPH04504256A (ja) 1992-07-30
RU2078770C1 (ru) 1997-05-10
EP0464124A1 (de) 1992-01-08
ES2050435T3 (es) 1994-05-16
CA2049325C (en) 2000-07-25
HUT62916A (en) 1993-06-28
HU902930D0 (en) 1991-12-30
NL8900726A (nl) 1990-10-16
DE69007616D1 (de) 1994-04-28
WO1990011298A1 (en) 1990-10-04
CA2049325A1 (en) 1990-09-24

Similar Documents

Publication Publication Date Title
ES2050435T3 (es) Una preparacion medicinal o vacuna y composicion inmunogenica peptida, un metodo de inmunizacion de un mamifero contra lhrh, y un metodo para mejorar la calidad carnica del ganado porcuno.
RU2221045C2 (ru) ОМР26 АНТИГЕН Haemophilus influenzae, КОДИРУЮЩАЯ ЕГО НК И ЕГО ИСПОЛЬЗОВАНИЕ
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
BR9814473A (pt) Imunógenos anti-retrovirais, preparação e uso
ATE127345T1 (de) Stressproteine und verwendungen dafür.
CY2612B2 (en) Compounds for immunotherapy and diagnosis of tuberculosis
ATE411043T1 (de) Verfahren von dna-impfung
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
AR035586A1 (es) Composicion de vacuna, equipo, metodos para incrementar la respuesta inmune, uso de un derivado de 1h-imidazo(4,5-c)quinolin-4-amina en la fabricacion de un medicamento, y combinacion de componentes para la administracion separada, secuencial o concomitante para el uso en la vacunacion de adn
CO5280094A1 (es) Un analogo de a o app y una composicion inmunogenica que comprende dicho analogo
NO991694L (no) Forbindelser og metoder for immunoterapi og diagnose av tuberkulose
RU98101249A (ru) Омр26 антиген haemophylus influenzae
DK0896583T3 (da) Anvendelse af peptidfragmenter fra OspC til diagnostiske metoder
ID24174A (id) Vector dari porcine adenovirus
DE69716240D1 (de) Neue methode zur impfung sowie impfstoffe dafür, die eine epitopkodierende nukleinsäure und ein epitopenthaltende peptid beinhalten
IL276661B2 (en) Immunogenic preparation containing staphylococcal antigens
GB9219936D0 (en) Vaccines
BR9812240A (pt) Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica
HUP0001431A3 (en) An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh , and analogs of the lhrh tandem repeat peptide and their use as vaccine
EP0236977A3 (de) Impfstoffe gegen Rindervirus-Diarrhoe und Schweine-Cholera
CA2516661A1 (en) M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
RU98112608A (ru) Иммуногенная композиция [на основе] tlp
ATE310750T1 (de) Verotoxin b untereinheit zur immunisierunug
FR2646776B1 (fr) Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
RU2003110420A (ru) Дифференцирование gnrh-i и gnrh-ii